Publications by Zhaoru Dong

Publications by authors named "Zhaoru Dong"

Claim this Profile

A pathomics-integrated multimodal model to evaluate chemoimmunotherapy efficacy in unresectable intrahepatic cholangiocarcinoma.

Qi-Hang Cao, Han Li, Peng-Fei Sun, Dong-Hai Lu, Bao-Wen Tian, Zhao-Ru Dong, Dong-Xu Wang

JHEP Rep· November 2025

Social Media Activity not collected for this article yet.

Response to "expanding the clinical and Immunogenomic relevance of SAMD1 in hepatocellular carcinoma".

Guo-Qiang Pan, Yu-Chuan Yan, Rui-Zhe Li, Zhao-Ru Dong, Tao Li

Metabolism· October 2025

Social Media Activity not collected for this article yet.

Hypoxia-Induced Creatine Uptake Reprograms Metabolism to Antagonize PARP1-Mediated Cell Death and Facilitate Tumor Progression in Hepatocellular Carcinoma.

Rui-Zhe Li, Guo-Qiang Pan, Chen Xiong, Zi-Niu Ding, Tuan-Song Zhang, Dongxu Wang, Xiao-Feng Dong, Rui Dong, Zhao-Ru Dong

Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response.

Guo-Qiang Pan, Yu-Chuan Yan, Rui-Zhe Li, Chen Xiong, Shao-Peng Zhang, Rui Dong, Xiao-Feng Dong, Dong-Xu Wang, Zhao-Ru Dong

Metabolism· September 2025

Social Media Activity not collected for this article yet.

Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma.

Yu-Chuan Yan, Li-Juan Shao, Guang-Xiao Meng, Guo-Qiang Pan, Rui-Zhe Li, Xiao-Feng Dong, Zhao-Ru Dong

Cell Death Dis· August 2025

Social Media Activity not collected for this article yet.

Systemic therapy plus HAIC versus systemic therapy for hepatocellular carcinoma: a systematic review and meta-analysis.

Donghai Lu, Han Li, Pengfei Sun, Jincheng Tian, Kefan Jiao, Zhaoru Dong, Dongxu Wang

Int J Surg· May 2025

Social Media Activity not collected for this article yet.

An umbrella review of the association between dietary factors and hepatocellular carcinoma risk.

Han Li, Qi-Hang Cao, Hui Liu, Lun-Jie Yan, Zi-Niu Ding, Rui Dong, Zhao-Ru Dong, Dong-Xu Wang

Food Funct· May 2025

Social Media Activity not collected for this article yet.

Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolism.

Chun-Cheng Yang, Yu-Chuan Yan, Guo-Qiang Pan, Guang-Xiao Meng, Xiao Zhang, Dong-Xu Wang, Zhao-Ru Dong

Cell Death Discov· March 2025

Social Media Activity not collected for this article yet.

Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis.

Shi-Jia Liu, Xiao Zhang, Lun-Jie Yan, Han-Chao Wang, Zi-Niu Ding, Zhao-Ru Dong, Dong-Xu Wang

J Cancer Res Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis.

Shi-Jia Liu, Lun-Jie Yan, Han-Chao Wang, Zi-Niu Ding, Hui Liu, Zhao-Ru Dong, Dong-Xu Wang

Oncologist· November 2024

Social Media Activity not collected for this article yet.

Spatial resolved transcriptomics reveals distinct cross-talk between cancer cells and tumor-associated macrophages in intrahepatic cholangiocarcinoma.

Zhao-Ru Dong, Meng-Ya Zhang, Ling-Xin Qu, Jie Zou, Yong-Heng Yang

Biomark Res· September 2024

Social Media Activity not collected for this article yet.

Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysis.

Qi-Hang Cao, Hui Liu, Lun-Jie Yan, Han-Chao Wang, Zi-Niu Ding, Zhao-Ru Dong, Dong-Xu Wang

J Gastroenterol Hepatol· August 2024

Social Media Activity not collected for this article yet.

Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway.

Guang-Zhen Li, Guang-Xiao Meng, Guo-Qiang Pan, Xiao Zhang, Lun-Jie Yan, Dong-Xu Wang, Zhao-Ru Dong

Cancer Cell Int· July 2024

Social Media Activity not collected for this article yet.

DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression.

Siyu Tan, Xiao Zhang, Xiaowei Guo, Guoqiang Pan, Lunjie Yan, Dongxu Wang, Zhaoru Dong

Cell Death Dis· July 2024

Social Media Activity not collected for this article yet.

Neoadjuvant immunotherapy based on PD-1/L1 inhibitors for gastrointestinal tumors: a review of the rationale and clinical advances.

Dong-Xu Wang, Hui Liu, Jin-Cheng Tian, Dao-Lin Zhang, Lun-Jie Yan, Zhao-Ru Dong

Int J Surg· June 2024

Social Media Activity not collected for this article yet.

The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Cheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, Zi-Niu Ding, Hui Liu, Dong-Xu Wang, Zhao-Ru Dong

Expert Rev Anticancer Ther· May 2024

Social Media Activity not collected for this article yet.

Comprehensive molecular analysis identifies RET alterations association with response of ICIs in multi-immunotherapy cohorts.

Jun-Yu Long, Rui-Zhe Li, Dong-Xu Wang, Hui Liu, Jincheng Tian, Zhao-Ru Dong

Int Immunopharmacol· January 2024

Social Media Activity not collected for this article yet.

Construction of an anoikis‒related prognostic signature to predict immunotherapeutic response and prognosis in hepatocellular carcinoma.

Chen Xiong, Guoqiang Pan, Hanchao Wang, Guangxiao Meng, Lunjie Yan, Zhaoru Dong

J Cancer Res Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysis.

Han Li, Hui Liu, Lun-Jie Yan, Zi-Niu Ding, Xiao Zhang, Zhao-Ru Dong, Dong-Xu Wang

Expert Rev Gastroenterol Hepatol· November 2023

Social Media Activity not collected for this article yet.

Caffeine intake is associated with less severe depressive symptoms in noncancer populations: an analysis based on NHANES 2007-2016.

Long-Shan Yang, Ze-Yi Zhang, Lun-Jie Yan, Yu-Chuan Yan, Si-Yu Tan, Dong-Xu Wang, Zhao-Ru Dong

Nutr Res· October 2023

Social Media Activity not collected for this article yet.

A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients.

Xin-Cheng Mao, Shuo Shi, Lun-Jie Yan, Han-Chao Wang, Zi-Niu Ding, Dong-Xu Wang, Zhao-Ru Dong

Biomark Res· October 2023

Social Media Activity not collected for this article yet.

Regional and sex differences in the mortality risk associated with primary liver cancer in obesity: A systematic review and meta-analysis.

Long-Shan Yang, Lun-Jie Yan, Yu-Chuan Yan, Zi-Niu Ding, Hui Liu, Zhao-Ru Dong, Dong-Xu Wang

Nutrition· September 2023

Social Media Activity not collected for this article yet.

MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway.

Guang-Zhen Li, Guang-Xiao Meng, Guo-Qiang Pan, Xiao Zhang, Lun-Jie Yan, Dong-Xu Wang, Zhao-Ru Dong

Cancer Cell Int· August 2023

Social Media Activity not collected for this article yet.

Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity.

Yu-Chuan Yan, Guang-Xiao Meng, Chun-Cheng Yang, Ya-Fei Yang, Si-Yu Tan, Zhao-Ru Dong

Cell Death Dis· July 2023

Social Media Activity not collected for this article yet.

The relationship between the serum lipid profile and hepatocellular carcinoma in east Asian population: A mendelian randomization study.

Guo-Qiang Pan, Yan Jiao, Guang-Xiao Meng, Zhao-Ru Dong, Tao Li

Heliyon· June 2023

Social Media Activity not collected for this article yet.

Socials: